Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Tries To Put Ambien Sleepwalking Fears To Bed

This article was originally published in The Pink Sheet Daily

Executive Summary

A full-page newspaper ad presenting "the real Ambien story" defends sleepwalking as a "possible rare side effect" specified on labeling.

You may also be interested in...



Ambien Publicity Sets The Whole Class On Snooze, Sanofi Says

Despite an initial dip in sales during Q1 stemming from a class action suit, Sanofi-Aventis says growth of the insomnia drug returned to previous levels.

Ambien Publicity Sets The Whole Class On Snooze, Sanofi Says

Despite an initial dip in sales during Q1 stemming from a class action suit, Sanofi-Aventis says growth of the insomnia drug returned to previous levels.

Ambien Nightmare? Sanofi Marketing Targeted In Civil Class Action

A class action suit alleges Sanofi-Aventis failed to adequately warn patients of the risk of sleep walking and sleep eating associated with the insomnia product.

Topics

UsernamePublicRestriction

Register

PS142351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel